Sweden vs Venezuela: The number of people with susceptibility test result for rifampicin
Sweden
173
in 2021
Venezuela
198
in 2021
Sweden rank
97th
Venezuela rank
94th
The number of people with susceptibility test result for rifampicin over time
- Sweden
- Venezuela
How they compare
Venezuela currently reports 198 against 173 in Sweden, a difference of 25.
That makes Venezuela's figure about 1.1 times Sweden's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Venezuela ahead.
Sweden ranks 97th and Venezuela ranks 94th of 155 countries.
Across the 2 decades both report, Sweden averaged higher in 1 and Venezuela in 1.
Head to head by decade
| Decade | Sweden | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 255 | 383 | 128 | Venezuela |
| 2020s | 171 | 152.5 | 18.5 | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Sweden or Venezuela?
- Venezuela, at 198 against 173 in Sweden as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Sweden and Venezuela?
- 25, with Venezuela ahead.
- How many years of comparable data are there for Sweden and Venezuela?
- 5 years are reported by both, from 2017 to 2021.
- How do Sweden and Venezuela rank globally for the number of people with susceptibility test result for rifampicin?
- Sweden ranks 97th and Venezuela ranks 94th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.